Beatriz Grinsztejn

Beatriz Grinsztejn

UNVERIFIED PROFILE

Are you Beatriz Grinsztejn?   Register this Author

Register author
Beatriz Grinsztejn

Beatriz Grinsztejn

Publications by authors named "Beatriz Grinsztejn"

Are you Beatriz Grinsztejn?   Register this Author

98Publications

2261Reads

10Profile Views

Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline.

Lancet HIV 2019 Nov 23;6(11):e788-e799. Epub 2019 Sep 23.

National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(19)30238-3DOI Listing
November 2019

The HIV epidemic in Latin America: accomplishments and challenges on treatment and prevention.

Curr Opin HIV AIDS 2019 Sep;14(5):366-373

Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COH.0000000000000564DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688714PMC
September 2019

Optimising HIV programming for transgender women in Brazil.

Cult Health Sex 2019 May 31;21(5):543-558. Epub 2018 Oct 31.

a Department of Medicine, Division of Prevention Sciences , University of California , San Francisco , CA , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/13691058.2018.1
Publisher Site
http://dx.doi.org/10.1080/13691058.2018.1496277DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483864PMC
May 2019

Effectiveness of direct-acting agents for hepatitis C and liver stiffness changing after sustained virological response.

J Gastroenterol Hepatol 2019 May 7. Epub 2019 May 7.

Laboratory of Clinical Research on STD/AIDS, Evandro Chagas National Institute of Infectious Disease (INI)-Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14707DOI Listing
May 2019

Health-related quality of life assessment among people living with HIV in Rio de Janeiro, Brazil: a cross-sectional study.

Qual Life Res 2019 Apr 10;28(4):1035-1045. Epub 2018 Nov 10.

Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Avenida Brasil, Manguinhos, Rio de Janeiro, 4365, Rio de Janeiro, RJ, 21040-360, Brazil.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11136-018-2044-8
Publisher Site
http://dx.doi.org/10.1007/s11136-018-2044-8DOI Listing
April 2019

Severe infection increases cardiovascular risk among HIV-infected individuals.

BMC Infect Dis 2019 Apr 11;19(1):319. Epub 2019 Apr 11.

Laboratório de Pesquisa Clínica em Medicina Intensiva, Instituto Nacional de Infectologia Evandro Chagas (INI), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-019-3894-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460818PMC
April 2019

Barriers and facilitators to PrEP for transwomen in Brazil.

Glob Public Health 2018 Aug 7:1-9. Epub 2018 Aug 7.

b Instituto Nacional de Infectologia (INI) Evandro Chagas , Fundacao Oswaldo Cruz , Fiocruz , Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17441692.2018.1505933DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367049PMC
August 2018

Age-Standardized Mortality Rates Related to Cirrhosis in Brazil from 2000 to 2012: A nationwide Analysis.

Ann Hepatol 2017 March-April;16(2):269-278

Evandro Chagas National Institute of Infectious Disease (INI) - Fundação Oswaldo Cruz (FIOCRUZ), Laboratory of clinical research on STD/AIDS, Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/16652681.1231586DOI Listing
July 2018

PrEP adopted by the brazilian national health system: What is the size of the demand?

Medicine (Baltimore) 2018 May;97(1S Suppl 1):S75-S77

Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000010602DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991536PMC
May 2018

Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil.

Int J Infect Dis 2018 Apr 15;69:11-19. Epub 2017 Dec 15.

Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijid.2017.12.014DOI Listing
April 2018

Syndemics among individuals enrolled in the PrEP Brasil Study.

Drug Alcohol Depend 2018 04 10;185:168-172. Epub 2018 Feb 10.

National Institute of Infectology Evandro Chagas, Lapclin STD/AIDS, Avenida Brasil 4.365, Fiocruz, Rio de Janeiro, Brazil. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2017.12.016DOI Listing
April 2018

Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study.

Infection 2017 Dec 28;45(6):801-809. Epub 2017 Jun 28.

Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Avenida Brasil 4365-Manguinhos, Rio de Janeiro, RJ, CEP 21.040-900, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s15010-017-1041-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873951PMC
December 2017

Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052.

J Acquir Immune Defic Syndr 2017 12;76(4):388-393

*Department of Pathology, Johns Hopkins Hospital, Baltimore, MD;†Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA;‡Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD;§FHI 360, Washington, DC;‖FHI 360, Durham, NC;¶Research Institute for Health Sciences, Chiang Mai University, Chaing Mai, Thailand;#University of North Carolina at Chapel Hill, Chapel Hill, NC;**UNC Project-Malawi, Institute for Global Health and Infectious Diseases, Lilongwe, Malawi;††YRGCARE Medical Centre, VHS, Chennai, India;‡‡College of Medicine-Johns Hopkins Project, Blantyre, Malawi;§§Instituto Nacional de Infectologia Evandro Chagas-INI-Fiocruz, Rio de Janeiro, Brazil;‖‖Hospital Geral de Nova Iguacu and Laboratorio de AIDS e Imunologia Molecular-IOC/Fiocruz, Rio de Janeiro, Brazil;¶¶Hospital Nossa Senhora da Conceição, Porto Alegre RS, Brazil;##Botswana Harvard AIDS Institute, Gaborone, Botswana;***Kenya Medical Research Institute, Kisumu, Kenya;†††Center for Disease Control, Kisumu, Kenya;‡‡‡University of the Witwatersrand, Perinatal HIV Research Unit, Soweto HPTN CRS, Soweto, South Africa;§§§University of Witwatersrand, Johannesburg, South Africa;‖‖‖Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; and¶¶¶Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00126334-201712010-0000
Publisher Site
http://dx.doi.org/10.1097/QAI.0000000000001511DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659928PMC
December 2017

Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older.

J Acquir Immune Defic Syndr 2017 11;76(3):311-318

1Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA; 2Sorbonne Universités, INSERM, UPMC Univ Paris 06, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France; 3Institute of Global Health, University College London, London, United Kingdom; 4Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, Madrid, Spain; 5CIBERESP, Instituto de Salud Carlos III, Madrid, Spain; 6AP-HP, Hôpital Antoine Béclère, Service de Médecine Interne, Clamart, France; 7Stichting HIV Monitoring, Amsterdam, the Netherlands; 8Academic Medical Centre, Department of Global Health and Division of Infectious Diseases, University of Amsterdam, Amsterdam, the Netherlands; 9Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands; 10Hospital San Pedro-CIBIR, Logroño, Spain; 11Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Basel, Switzerland; 12Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; 13Infectious Disease Department, Hospital Parc Tauli, Sabadell, Spain; 14Hospital Clinic-IDIBAPS, Barcelona, Spain; 15Division of Infectious Diseases, Patras University Hospital, Patras, Greece; 16Department of Hygiene, Epidemiology and Medical Statistics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece; 17Université de Bordeaux, ISPED, Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France; 18Centre INSERM U1219- Centre Inserm Epidémiologie et Biostatistique, Université de Bordeaux, Bordeaux, France; 19Department of Internal Medicine, Bordeaux University Hospital, Bordeaux, France; 20Université Paris Sud, UMR 1018, le Kremlin Bicêtre, Paris, France; 21Inserm, UMR 1018, le Kremlin Bicêtre, Paris, France; 22AP-HP, Hôpital de Bicêtre, Service de Santé Publique, le Kremlin Bicêtre, Paris, France; 23Southern Alberta Clinic, Calgary, AB, Canada; 24Department of Medicine, University of Calgary, Calgary, AB, Canada; 25Instituto Nacional de Infectologia Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brasil; 26Programa de Computação Científica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brasil; 27Hospital Universitari Germans Trias i Pujol, Badalona, Spain; 28Department of Internal Medicine, Yale University School of Medicine, New Haven; 29VA Connecticut Healthcare System, West Haven, CT; 30Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston; and 31Harvard-MIT Division of Health Sciences and Technology, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001498DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704899PMC
November 2017

Self-rated health and substance use among individuals in HIV care in Rio de Janeiro, Brazil: a cross-sectional study.

Int J STD AIDS 2017 10 2;28(12):1175-1183. Epub 2017 Feb 2.

3 Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0956462417692278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501998PMC
October 2017

Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis.

J Acquir Immune Defic Syndr 2017 10;76(2):177-182

*Departments of Epidemiology and Biostatistics; †Medicine,University of California, San Francisco, San Francisco, CA; ‡Department of Health Services, University of Washington, Seattle, WA; §Department of Pharmaceutical Sciences, University of Colorado, Denver, Aurora, CO; ∥Investigaciones Médicas en Salud, Lima, Peru; ¶Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand; #Bridge HIV, San Francisco Department of Public Health, San Francisco, CA; **Department of Medicine, Desmond Tutu HIV Foundation, Cape Town, South Africa; ††Projeto Praça Onze, Hospital Escola São Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; ‡‡Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro, Brazil; and §§Gladstone Institute of Virology and San Francisco AIDS Foundation, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001475DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597476PMC
October 2017

Substance use among HIV-infected patients in Rio de Janeiro, Brazil: Agreement between medical records and the ASSIST questionnaire.

Drug Alcohol Depend 2017 09 16;178:115-118. Epub 2017 Jun 16.

Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos Rio de Janeiro, RJ, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2017.04.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712472PMC
September 2017

Asymptomatic anorectal Chlamydia trachomatis and Neisseria gonorrhoeae infections are associated with systemic CD8+ T-cell activation.

AIDS 2017 09;31(15):2069-2076

aDivision of Clinical Immunology and Allergy bDepartment of Infectious and Parasitic Diseases, University of São Paulo School of Medicine cInstituto de Ensino e Pesquisa, Hospital Sírio-Libanês dCentro de Referência e Treinamento em DST/AIDS, São Paulo, São Paulo eInstituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001580DOI Listing
September 2017

Thirty-day Readmission Rates in an HIV-infected Cohort From Rio de Janeiro, Brazil.

J Acquir Immune Defic Syndr 2017 08;75(4):e90-e98

Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484736PMC
August 2017

Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection.

PLoS One 2017 22;12(3):e0174453. Epub 2017 Mar 22.

Laboratório de Pesquisa Clínica em DST/AIDS (LAPCLIN-AIDS), Instituto Nacional de Infectologia Evandro Chagas - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0174453PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362235PMC
August 2017

Transmitted drug resistance in patients with acute/recent HIV infection in Brazil.

Braz J Infect Dis 2017 Jul - Aug;21(4):396-401. Epub 2017 May 21.

Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bjid.2017.03.013DOI Listing
August 2017

Towards an ideal antiretroviral regimen for the global HIV epidemic.

J Virus Erad 2017 Jul 1;3(3):111-116. Epub 2017 Jul 1.

Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518238PMC
July 2017

Age-standardized mortality rates related to viral hepatitis in Brazil.

BMC Infect Dis 2017 07 31;17(1):527. Epub 2017 Jul 31.

Fundação Oswaldo Cruz (FIOCRUZ), Instituto Nacional de Infectologia Evandro Chagas (INI), Laboratório de Pesquisa Clínica em DST e AIDS (LAPCLIN-AIDS), Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-017-2619-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537933PMC
July 2017

Hospitalization rates, length of stay and in-hospital mortality in a cohort of HIV infected patients from Rio de Janeiro, Brazil.

Braz J Infect Dis 2017 Mar - Apr;21(2):190-195. Epub 2016 Dec 3.

Fundação Oswaldo Cruz (FIOCRUZ), Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bjid.2016.10.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489121PMC
June 2017

[Vulnerability to HIV infection in serodiscordant couples in Rio de Janeiro, Brazil].

Cad Saude Publica 2017 Jun 1;33(4):e00053415. Epub 2017 Jun 1.

Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1590/0102-311X00053415DOI Listing
June 2017

First Report of Prevalence of HTLV-1 Among HIV-1/2-Infected Children in Mozambique.

J Acquir Immune Defic Syndr 2017 02;74(2):e54-e56

*National Tuberculosis Control Program, National Directorate for Public Health, Ministry of Health, Maputo, Mozambique †Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique ‡Instituto Nacional de Infectologia, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil §Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001194DOI Listing
February 2017

Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial.

J Acquir Immune Defic Syndr 2017 Jan;74(1):112-116

*Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD; †Laboratory of Immunoregulation, NIAID, NIH, Baltimore, MD; ‡Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC; §Vaccine and Infectious Disease Science Division, Fred Hutchinson Cancer Research Institute, Seattle, WA; ‖Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC; ¶Genomics Unit, Research Technologies Section, Rocky Mountain Laboratories, DIR, NIAID, NIH, Hamilton, MT; #Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; **Science Facilitation Department, FHI360, Washington, DC; ††Science Facilitation Department, FHI360, Durham, NC; ‡‡College of Medicine-Johns Hopkins Project, Blantyre, Malawi; §§UNC Project, Lilongwe, Malawi; ‖‖Department of Medicine, University of Zimbabwe, Harare, Zimbabwe; ¶¶HIV Research Branch, Center for Global Health, Kenya Medical Research Institute (KEMRI)-Centers for Disease Control (CDC), Kisumu, Kenya; ##BHHRL & Clinical Trials Unit, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; ***Soweto HPTN CRS, Chris Hani Baragwanath Hospital, Soweto, South Africa; †††YRGCARE Medical Centre, Chennai, India; ‡‡‡Center for AIDS and STDs, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand; §§§Hospital Nossa Senhora da Conceição, Serviço de Infectologia, Porto Alegre, Brazil; ‖‖‖Hospital Geral de Nova Iguaçu and Laboratorio de AIDS e Imunologia Molecular (IOC/Fiocruz), Rio de Janeiro, Brazil; ¶¶¶Instituto Nacional de Infectologia Evandro Chagas-INI-Fiocruz, Rio de Janeiro, Brazil; ###Fenway Health and Infectious Disease Division, The Fenway Institute, Boston, MA; ****Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA; ††††Vaccine and Infectious Disease Division and Public Health Science Division, Fred Hutchinson Cancer Research Institute, Seattle, WA; ‡‡‡‡Department of Biostatistics, University of Washington, Seattle, WA; and §§§§Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140698PMC
January 2017

HIV/AIDS prevention, care and treatment in the Region of the Americas: achievements, challenges and perspectives.

Rev Panam Salud Publica 2016 12;40(6):398-400

HIV, Hepatitis, Tuberculosis and STI Unit, Pan American Health Organization, Washington, D.C., United States of America.

View Article

Download full-text PDF

Source
December 2016

Age-Standardized Mortality Rates Related to Cirrhosis in Brazil from 2000 to 2012: A Nationwide Analysis.

Ann Hepatol 2017 Mar - Apr;16(2):269-278

Evandro Chagas National Institute of Infectious Disease (INI) - Fundação Oswaldo Cruz (FIOCRUZ), Laboratory of clinical research on STD/AIDS, Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/16652681.1231588DOI Listing
May 2015